Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00910559 · ClinicalTrials.gov registry record

Phenotypic and Genetic Factors in Autism Spectrum Disorders

A clinical trial of Autism Spectrum Disorders, sponsored by Boston Children's Hospital.

Active
Registry status
1,500
Enrollment target
1
Study location

NCT00910559: Active study of Autism Spectrum Disorders, sponsored by Boston Children's Hospital.

NCT00910559 is a study of Autism Spectrum Disorders that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 1,500 participants, above the 93-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (1513% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00910559, a study of Autism Spectrum Disorders, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
1,500 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.

Conditions Studied

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2008-07
Est. Completion 2030-02
Boston Children's Hospital

462 total trials

What the registry record for NCT00910559 still lists

NCT00910559 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 93-participant average among 20 other Autism Spectrum Disorders trials with a reported enrollment target (1513% higher).

The record links to 1 condition, with Autism Spectrum Disorders appearing as the primary indexed condition, and to 0 interventions.

NCT00910559 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00910559 about?

NCT00910559 is a clinical study titled "Phenotypic and Genetic Factors in Autism Spectrum Disorders". The purpose of the study is to collect phenotypic (observable characteristics) and genetic information about individuals with Autism Spectrum Disorders (ASDs) and their families.

What is the current status of trial NCT00910559?

This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2008-07. Estimated completion is 2030-02.

What conditions does trial NCT00910559 study?

This clinical trial studies the following conditions: Autism Spectrum Disorders.

Who is sponsoring clinical trial NCT00910559?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00910559 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00910559's enrollment target sits among peer trials

1,500 1st of 20 higher than 20 of 20 other Autism Spectrum Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Autism Spectrum Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00910559, the US trial registry maintained by the National Library of Medicine. NCT00910559 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.